Targeting the cognition-action network improves Parkinson's treatment efficacy

Parkinson's treatments may be more effective by targeting the cognition-action network in the brain. A study found that treatments reduced hyperconnectivity in this network, bringing it closer to healthy levels. Targeting this network doubled the efficacy of some treatments. This suggests Parkinson's is a SCAN disorder, and personalized targeting could improve treatment outcomes and potentially slow disease progression.